Clinical Biomarkers & World CDx Europe Summit
May 1 - May 3
Future Diagnostics Solutions is proud to exhibit at the Clinical Biomarkers & World CDx Europe Summit. It will take place in London, UK, from May 1st until 3rd, 2018.
Improve the Development and Clinical Validation of Novel Predictive Biomarker Signatures to Better Demonstrate Efficacy for Targeted Therapeutics and Accelerate the Commercialisation of Dx-Enabled Precision Medicines.
The Summit is back to provide much need clarity for pharmaceutical, biotech, healthcare and diagnostic leaders in the precision medicine industry. The event will provide you with the insight needed to successfully validate and apply patient stratifying biomarkers to boost the approval, launch and adoption of targeted therapies.
What’s new for 2018?
Clinical Biomarkers. One stream this year is solely dedicated for translational and biomarker scientists looking to develop and clinically validate novel predictive biomarker signatures to drive the demonstration of efficacy and approval of precision medicines.
The European IVDR. Addressing the changing landscape for IVDs in Europe, the focus is on revamping Dx strategy to overcome European challenges in the up-regulation of IVDs to ensure successful co-development, launch and adoption of future drug-Dx products.
New representation from more demographics. Whether you’re looking to engage and network with biomarker, translational and diagnostic scientists or have a more strategic discussion senior departmental heads, this is covered . New representation from notified bodies, regulators, payers and healthcare institutions will also be present.